Seong-Chul Kim
Direttore/Membro del Consiglio presso KPS CORPORATION
Patrimonio netto: 3 M $ in data 31/05/2024
Profilo
Seong-Chul Kim is the founder of Elevar Therapeutics, Inc. which was founded in 2005.
He held the titles of President, Chief Executive Officer & Director.
Currently, he is a Director at KPS Corp.
(South Korea) where he still holds a job.
In the past, he worked as Co-Chief Executive Officer at LSK Investment Co. Ltd.
from 2016 to 2018 and as Director & Head-Bio at HLB Co., Ltd.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
KPS CORP
2.94% | 03/04/2024 | 550 458 ( 2.94% ) | 3 M $ | 31/05/2024 |
Posizioni attive di Seong-Chul Kim
| Società | Posizione | Inizio |
|---|---|---|
| KPS CORPORATION | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Seong-Chul Kim
| Società | Posizione | Fine |
|---|---|---|
LSK Investment Co. Ltd.
 LSK Investment Co. Ltd. Investment ManagersFinance LSK Investment Co. Ltd. (LSK Investment), a private equity & venture capital subsidiary of HLB Life Science Co Ltd., was founded in 2016. The firm is headquartered in Seoul, South Korea. | Amministratore Delegato | 31/12/2018 |
Elevar Therapeutics, Inc.
 Elevar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elevar Therapeutics, Inc. engages in the provision of biopharmaceutical services. It offers Rivoceranib, a small-molecule angiogenesis inhibitor in gastric cancer that use in the growth and proliferation in cancer cells. The company was founded by Sung Chul Kim and Soo Whan Choi in 2005 and is headquartered in Salt Lake City, UT. | Fondatore | - |
| HLB CO., LTD. | Direttore/Membro del Consiglio | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| HLB CO., LTD. | Health Technology |
| Aziende private | 3 |
|---|---|
Elevar Therapeutics, Inc.
Elevar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elevar Therapeutics, Inc. engages in the provision of biopharmaceutical services. It offers Rivoceranib, a small-molecule angiogenesis inhibitor in gastric cancer that use in the growth and proliferation in cancer cells. The company was founded by Sung Chul Kim and Soo Whan Choi in 2005 and is headquartered in Salt Lake City, UT. | Health Technology |
| KPS Corp. (South Korea) | |
LSK Investment Co. Ltd.
LSK Investment Co. Ltd. Investment ManagersFinance LSK Investment Co. Ltd. (LSK Investment), a private equity & venture capital subsidiary of HLB Life Science Co Ltd., was founded in 2016. The firm is headquartered in Seoul, South Korea. | Finance |
- Borsa valori
- Insiders
- Seong-Chul Kim
